ABMT OTC
Advanced BioMedical Technologies Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +25.0%
1Y: +400.0%
3Y: -98.8%
5Y: -99.6%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$271K
+58.3% ▲
Gross Profit
$222K
+137.8% ▲
Operating Income
-$180K
+54.4% ▲
Net Income
-$515K
+29.3% ▲
EPS (Diluted)
$-0.01
+29.8% ▲
EBITDA
-$166K
+54.8% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $0 | $12K | $124K | $171K | $271K |
| YoY Growth | +0.0% | +0.0% | +960.2% | +38.5% | +58.3% |
| Cost of Revenue | $0 | $8K | $52K | $78K | $49K |
| Gross Profit | $0 | $4K | $72K | $93K | $222K |
| Gross Margin | — | 34.8% | 58.1% | 54.5% | 81.9% |
| R&D Expenses | $57K | $264K | $183K | $230K | $186K |
| SG&A Expenses | $561K | $324K | $275K | $258K | $216K |
| Operating Expenses | $634K | $609K | $518K | $488K | $402K |
| Operating Income | -$634K | -$605K | -$447K | -$395K | -$180K |
| Operating Margin | — | -5187.8% | -361.4% | -230.7% | -66.4% |
| Interest Expense | $301K | $326K | $329K | $321K | $331K |
| Income Before Tax | -$953K | -$949K | -$672K | -$729K | -$515K |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$953K | -$949K | -$672K | -$729K | -$515K |
| Net Margin | — | -8139.5% | -543.7% | -426.1% | -190.2% |
| EPS (Diluted) | $-0.01 | $-0.01 | $-0.01 | $-0.01 | $-0.01 |
| EBITDA | -$636K | -$601K | -$283K | -$367K | -$166K |
| Shares Outstanding | 69M | 70M | 70M | 70M | 71M |